Click a link below to view the mailing archive as if it had been sent to you.
| 2021-02-25 12:15 | | Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche and more... |
| 2021-02-25 00:15 | | Pfizer-BioNTech vaccine performs as well in the real world as in clinical trials, new study concludes and more... |
| 2021-02-24 12:15 | | FDA scientists endorse J&J’s Covid vaccine, as new data shed light on efficacy and more... |
| 2021-02-24 00:15 | | AstraZeneca expects U.S. COVID-19 vaccine authorization in April and more... |
| 2021-02-23 12:15 | | Bristol Myers scales up cell therapy production with liso-cel nod in hand and another approval maybe on the way and more... |
| 2021-02-23 00:15 | | 'Real-world' UK data shows 70% decline in COVID infections after first Pfizer shot and more... |
| 2021-02-22 12:15 | | U.S. edges closer to half a million COVID deaths as experts look to FDA meeting on J&J’s one-dose vaccine and more... |
| 2021-02-22 00:15 | | As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing and more... |
| 2021-02-21 00:15 | | Everlywell gets green light to sell at-home Covid-19 test kit without prescription and more... |
| 2021-02-19 12:15 | | Data finds Pfizer vaccine highly effective after first dose, can be stored in normal freezers and more... |
| 2021-02-19 00:15 | | Novavax, coronavirus shot data in hand, strikes an eye-popping supply deal with global vaccine consortium and more... |
| 2021-02-18 12:15 | | A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice and more... |
| 2021-02-18 00:15 | | In first for the world, Britain OKs challenge trial exposing volunteers to COVID-19 and more... |
| 2021-02-17 12:15 | | Moving up the lines, AstraZeneca stakes another PhIII win for Lynparza as adjuvant breast cancer therapy and more... |
| 2021-02-17 00:15 | | Drugmakers struggle to get volunteers for COVID-19 vaccine clinical trials as more people opt for approved shots and more... |
| 2021-02-16 12:15 | | Bluebird stops studies of sickle cell gene therapy after new cancer cases and more... |
| 2021-02-16 00:15 | | Can Pfizer and Moderna End the Pandemic by Sharing Their Vaccine Designs? It’s Not that Simple and more... |
| 2021-02-15 12:15 | | The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week and more... |
| 2021-02-15 00:15 | | Here's Why the Novavax Vaccine May Have to Wait for FDA Authorization and more... |
| 2021-02-14 00:15 | | A pair of biotechs prepares to hit Nasdaq, as total 2021 IPO raise quickly approaches $3B and more... |
| 2021-02-12 12:15 | | GlaxoSmithKline to shut down antibiotics production, cut 300 jobs in wake of Novartis buyout and more... |
| 2021-02-12 00:15 | | Bristol Myers Takes $470 Million Write-off and Scraps Orva-Cel CAR-T Program and more... |
| 2021-02-11 12:15 | | 3 Reasons Pfizer's Failures Could Lead to a Big Acquisition and more... |
| 2021-02-11 00:15 | | AbbVie adds to the Botox war chest with a 12th FDA approval — but competition is fast approaching and more... |
| 2021-02-10 12:15 | | Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer and more... |
| 2021-02-10 00:15 | | Johnson & Johnson CEO: Our Covid-19 Vaccine Will Keep You From Getting ‘Very, Very Sick’ and more... |
| 2021-02-09 12:15 | | Alinity, da Vinci top hospital purchasing execs' wish lists: UBS and more... |
| 2021-02-09 00:15 | | Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rivalrnings season continues to show COVID-19 uncertainty and more... |
| 2021-02-08 12:15 | | 4 in 5 Americans ready for COVID-19 shot, but vaccine messages remain key, analysis finds and more... |
| 2021-02-07 00:15 | | Bristol Myers Squibb's CAR-T liso-cel wins long-delayed FDA nod and more... |
| 2021-02-05 12:15 | | Sanofi flunks Parkinson's Phase II, axes handful of mid-stage programs in Q4 earnings and more... |
| 2021-02-05 00:15 | | J&J asks FDA for emergency clearance of coronavirus vaccine and more... |
| 2021-02-04 12:15 | | Merck’s Kenneth Frazier, biopharma’s irreplaceable voice, to step down as CEO and more... |
| 2021-02-04 00:15 | | Amgen cuts 'several hundred' U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital and more... |
| 2021-02-03 12:15 | | Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy and more... |
| 2021-02-03 00:15 | | Amgen Slips Even After Earnings and Revenue Beat Estimates and more... |
| 2021-02-02 12:15 | | FDA Action Alert: Adamas, Mallinckrodt and Merck and more... |
| 2021-02-02 00:15 | | Lilly drives more access to COVID-19 antibodies with new infusion centers and more... |
| 2021-02-01 12:15 | | While Pfizer and Moderna hold the lead, new data from J&J, Novavax show there's 'room for everyone' in the market: analysts and more... |
| 2021-02-01 00:15 | | Novavax CEO: UK data should be used for quicker U.S. COVID-19 vaccine rollout and more... |
